GSK Tops Third-Quarter Estimates as New Medicines Drive Growth, Maintains Outlook
Oct 28, 2026
GSK exceeded Q3 sales and profit expectations driven by strong demand for new medicines, maintaining annual targets while boosting R&D investment ahead of patent expiries.